RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Operating margin (%)

BrightPath Biotherapeutics Co., Ltd.【JP:4594】

Market cap
¥6.3B
P/E ratio
-5.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating margin (%) YoY (%)
Mar 31, 2025-102,464.1-93.61%
Mar 31, 2024-1,604,275+5673.85%
Mar 31, 2023-27,785.2+190.04%
Mar 31, 2022-9,579.7-86.16%
Mar 31, 2021-69,201.4+327.93%
Mar 31, 2020-16,171.2+1412.78%
Mar 31, 2019-1,069+142.59%
Mar 31, 2018-440.7+109.58%
Mar 31, 2017-210.3+74.92%
Mar 31, 2016-120.2+100.66%
Mar 31, 2015-59.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)